--- title: "Oxford Nanopore Technologies (LON:ONT) Insider Buys £24,826.50 in Stock" type: "News" locale: "en" url: "https://longbridge.com/en/news/298091895.md" description: "Oxford Nanopore Technologies insider Nick Keher purchased 15,325 shares valued at £24,826.50 on September 4th at GBX 162 per share. This follows previous small purchases in June, July, and August. The stock recently dropped 8.4%. Analysts maintain a 'Moderate Buy' consensus with an average price target of GBX 198.60, citing recent upgrades from Citigroup, JPMorgan, and Berenberg Bank." datetime: "2026-09-05T05:07:58.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/298091895.md) - [en](https://longbridge.com/en/news/298091895.md) - [zh-HK](https://longbridge.com/zh-HK/news/298091895.md) generator: "portal-rs" --- # Oxford Nanopore Technologies (LON:ONT) Insider Buys £24,826.50 in Stock Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Nick Keher bought 15,325 shares of the firm's stock in a transaction dated Friday, September 4th. The stock was purchased at an average price of GBX 162 per share, for a total transaction of £24,826.50. Nick Keher also recently made the following trade(s): - On Wednesday, August 12th, Nick Keher purchased 115 shares of Oxford Nanopore Technologies stock. The stock was purchased at an average cost of GBX 131 per share, for a total transaction of £150.65. - On Tuesday, July 14th, Nick Keher purchased 123 shares of Oxford Nanopore Technologies stock. The shares were purchased at an average price of GBX 121 per share, with a total value of £148.83. - On Friday, June 12th, Nick Keher purchased 121 shares of Oxford Nanopore Technologies stock. The shares were purchased at an average price of GBX 124 per share, with a total value of £150.04. ## Oxford Nanopore Technologies Stock Down 8.4% LON ONT opened at GBX 158.76 on Friday. The business has a fifty day moving average price of GBX 131.26 and a 200 day moving average price of GBX 124.84. The company has a debt-to-equity ratio of 9.86, a quick ratio of 6.01 and a current ratio of 3.52. The company has a market cap of £1.55 billion, a P/E ratio of -10.51 and a beta of 0.91. Oxford Nanopore Technologies plc has a one year low of GBX 95.61 and a one year high of GBX 191.40. * * * * * * Oxford Nanopore Technologies (LON:ONT - Get Free Report) last announced its earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative return on equity of 35.45% and a negative net margin of 54.66%. ## Wall Street Analysts Forecast Growth ONT has been the subject of several research reports. Citigroup cut shares of Oxford Nanopore Technologies to a "buy" rating in a research note on Monday, July 20th. Peel Hunt restated a "hold" rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a report on Monday, July 13th. Berenberg Bank dropped their price target on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating for the company in a research report on Wednesday, August 19th. JPMorgan Chase & Co. increased their price target on Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a report on Thursday, August 27th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Oxford Nanopore Technologies currently has an average rating of "Moderate Buy" and a consensus price target of GBX 198.60. **Read Our Latest Research Report on ONT** ## Oxford Nanopore Technologies Company Profile (Get Free Report) Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. ## See Also - Five stocks we like better than Oxford Nanopore Technologies - Revolution Medicines Got Its Breakthrough—What Moves It Next? - Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy - FB Financial's Southern Expansion and Buybacks Drive Analyst Optimism - AST SpaceMobile Stock Soared 12%—This Was the Catalyst *This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to \[email protected\].* Insider Buying or Selling at Oxford Nanopore Technologies? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Oxford Nanopore Technologies and related companies. From Our Partners Trump’s “new Petrodollar” exposed Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en... Porter & Company Musk says UBI is coming. I say it's already here. Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ... Freedom Financial After KDA, PRE, and OCEAN—this is the one 17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of... Crypto 101 Media Major Buy Alert Issued for September 30th Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ... TradeSmith Man Who Called SpaceX Rise Says Elon’s NEW Project is Even Bigger James Altucher called the rise of Nvidia, Apple, and SpaceX years before the crowd. Now he says he has uncover... Paradigm Press Half the market is standing on a trapdoor Nearly half the value of the US stock market now sits in AI stocks - the most concentrated the market has been... Behind the Markets Anthropic’s confidential SEC filing — and the public ticker that holds it Anthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio... The Oxford Club A New Approach to Retirement Income That Needs Less Capital The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco... Investors Alley ### Related Stocks - [ONT.US](https://longbridge.com/en/quote/ONT.US.md) - [C.US](https://longbridge.com/en/quote/C.US.md) - [JPM.US](https://longbridge.com/en/quote/JPM.US.md) - [RY.US](https://longbridge.com/en/quote/RY.US.md) - [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md) - [FBK.US](https://longbridge.com/en/quote/FBK.US.md) - [ASTS.US](https://longbridge.com/en/quote/ASTS.US.md) - [C-R.US](https://longbridge.com/en/quote/C-R.US.md) - [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md) - [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md) - [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md) - [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md) - [8634.JP](https://longbridge.com/en/quote/8634.JP.md) - [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md) - [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md) - [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md) ## Related News & Research - [Should You Investigate Oxford Nanopore Technologies plc (LON:ONT) At UK£1.61?](https://longbridge.com/en/news/298103630.md) - [REG - BlackRock Group Rotork PLC - Form 8.3 - Rotork plc](https://longbridge.com/en/news/297800453.md) - [REG - Shuka Minerals PLC - Further re Subscription](https://longbridge.com/en/news/297867499.md) - [REG - BlackRock Group SEGRO PLC - Form 8.3 - SEGRO plc](https://longbridge.com/en/news/297800413.md) - [Nick Keher Acquires 15,325 Shares of Oxford Nanopore Technologies (LON:ONT) Stock](https://longbridge.com/en/news/298035794.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**